Shanghai Haoyuan Chemexpress Co. Ltd. A - Asset Resilience Ratio
Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has an Asset Resilience Ratio of 0.96% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read how much debt does Shanghai Haoyuan Chemexpress Co. Ltd. A carry for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Shanghai Haoyuan Chemexpress Co. Ltd. A's Asset Resilience Ratio has changed over time. See shareholders equity of Shanghai Haoyuan Chemexpress Co. Ltd. A for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Shanghai Haoyuan Chemexpress Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shanghai Haoyuan Chemexpress Co. Ltd. A stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥58.12 Million | 0.96% |
| Total Liquid Assets | CN¥58.12 Million | 0.96% |
Asset Resilience Insights
- Limited Liquidity: Shanghai Haoyuan Chemexpress Co. Ltd. A maintains only 0.96% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shanghai Haoyuan Chemexpress Co. Ltd. A Industry Peers by Asset Resilience Ratio
Compare Shanghai Haoyuan Chemexpress Co. Ltd. A's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Zhejiang Huahai Pharmaceutical Co Ltd
SHG:600521 |
Drug Manufacturers - Specialty & Generic | 0.44% |
|
Emcure Pharmaceuticals Ltd
NSE:EMCURE |
Drug Manufacturers - Specialty & Generic | 1.38% |
|
Guangdong Zhongsheng Pharmaceutical Co Ltd
SHE:002317 |
Drug Manufacturers - Specialty & Generic | 6.62% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 2.69% |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI |
Drug Manufacturers - Specialty & Generic | 1.54% |
|
Changzhou Qianhong Biopharma Co Ltd
SHE:002550 |
Drug Manufacturers - Specialty & Generic | 20.24% |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799 |
Drug Manufacturers - Specialty & Generic | 0.40% |
Annual Asset Resilience Ratio for Shanghai Haoyuan Chemexpress Co. Ltd. A (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Shanghai Haoyuan Chemexpress Co. Ltd. A.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.16% | CN¥449.15 Million ≈ $65.72 Million |
CN¥5.50 Billion ≈ $805.55 Million |
+7.68pp |
| 2022-12-31 | 0.48% | CN¥17.23 Million ≈ $2.52 Million |
CN¥3.60 Billion ≈ $526.46 Million |
-- |
About Shanghai Haoyuan Chemexpress Co. Ltd. A
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.